China Nepstar Chain Drugstore Ltd. (NPD)

[fung_derf]

They signed a big contract recently. Surprised it's not higher.

[Bylerzone]

Looks like it could run up nicely if it breaks around $2.70 and throw in a tight stop loss or see if it retraces the 50 day @ $2.32 and possible bounce off that.

[stocktrademan]

$NPD recent news/filings

bullish

## source: finance.yahoo.com

Tue, 21 Apr 2015 22:12:10 GMT ~ Rite Aid (RAD) Appoints Rempel to Enhance IT Solutions - Analyst Blog


read full: http://finance.yahoo.com/news/rite-aid-rad-appoints-rempel-221210096.html
*********************************************************

Fri, 10 Apr 2015 11:44:11 GMT ~ Will China Nepstar Chain Drugstore (NPD) Continue to Surge Higher? - Tale of the Tape


read full: http://finance.yahoo.com/news/china-nepstar-chain-drugstore-npd-114411212.html
*********************************************************

Thu, 09 Apr 2015 13:00:01 GMT ~ Rite Aid (RAD) Tops Q4 Earnings and Sales, Guides FY16 - Analyst Blog


read full: http://finance.yahoo.com/news/rite-aid-rad-tops-q4-130001603.html
*********************************************************

Mon, 30 Mar 2015 12:00:00 GMT ~ China Nepstar Chain Drugstore Ltd Earnings Call scheduled for 8:00 am ET today


read full: http://biz.yahoo.com/cc/0/148590.html
*********************************************************

Mon, 30 Mar 2015 11:07:02 GMT ~ Q4 2014 China Nepstar Chain Drugstore Ltd Earnings Release - Before Market Open


read full: http://biz.yahoo.com/research/earncal/20150330.html?t=npd
*********************************************************

$NPD charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$NPD company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/NPD/company-info
Ticker: $NPD
OTC Market Place: Not Available
CIK code: 0001414850
Company name: China Nepstar Chain Drugstore Ltd.
Incorporated In:

$NPD share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.0001

$NPD extra dd links

Company name: China Nepstar Chain Drugstore Ltd.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NPD/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NPD/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NPD+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NPD+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NPD+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NPD/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/news - http://finance.yahoo.com/q/h?s=NPD+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NPD/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NPD/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NPD/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NPD/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NPD/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NPD/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NPD/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NPD+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NPD
DTCC (dtcc.com): http://search2.dtcc.com/?q=China+Nepstar+Chain+Drugstore+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=China+Nepstar+Chain+Drugstore+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=China+Nepstar+Chain+Drugstore+Ltd.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NPD/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NPD
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NPD/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NPD/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NPD/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001414850&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NPD/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NPD/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NPD&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NPD
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NPD+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NPD+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NPD
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NPD
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NPD+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NPD/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NPD+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NPD.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NPD
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NPD/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NPD/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NPD/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NPD/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NPD
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NPD
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NPD:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NPD
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NPD



$NPD DD Notes ~ http://www.ddnotesmaker.com/NPD

[Emilez]

Any opinions about this stock?

[temp luvs amy]

Nah, I just have free shares.

[fung_derf]

It's your money now.

[temp luvs amy]

Could even test the 200 at $1.76, but it's somebody elses money, and I don't really care about daily swings. I am in it for the long run, unless its real profitable in the short swing.

[fung_derf]

Looks like it dropped below it. Doubtful I would buy back in, but $2.05 looks very possible now. JMO, of course.

[temp luvs amy]

Story of my life....

I waited for the 50 DMA.

I only nibbled. Spent all the profit. No more.

[fung_derf]

you may be early

[temp luvs amy]

I got out too soon. I got back in today.

[fung_derf]

Looks like I got out at the right time.

[temp luvs amy]

I didn't even have to wait for a recession.

[fung_derf]

that's pretty good.

[temp luvs amy]

I try not to let the emotion of failure get to me after they run.

I can wait for the next recession. You know what they say?

A recession is when stocks return to their true owners.

[fung_derf]

Yeah, it's a tough company to find good research on, and since you were my source, if you sold, other than the charts, there wasn't much holding me in. I made 50% in two months so can't complain, but I typically find it best to quit watching after selling, as they tend to run after I sell.

[temp luvs amy]

You know they haven't even reported since we got in, and there is the pricing issue. It's that old bird in the hand concept. The bird bit me a bit early with this global turmoil in progress.

No news out of china. You never know why this went up, but I suspect an institution did their DD and jumped in big.

[fung_derf]

I went ahead and sold this morning. Got close enough to a resistance for me. May be early as this one may really have some wings, but it was a very nice trade. You get all the credit. Thanks.

[temp luvs amy]

I think they try to get cash to the shareholders at times when the management is able to do so with the blessing of the PRC.

[temp luvs amy]

Yeah, the flashy war sabers got me a bit jumpy, and I decided to rest a few positions.

This one was a Crimean casualty.

[fung_derf]

Can't figure out the dividend. It seems to pay whenever it feels like it. Wish I had caught the last one though.

[fung_derf]

LOL! Great. So did you sell? I decided to see what happens tomorrow morning. Need to remember to look.

[temp luvs amy]

IDK, Go with your instincts.

Mine aren't any good right now.

[fung_derf]

Really? It broke to the upside of the flag formation. Figured we might see one more flag? I was thinking closer to $3.50 at least?

[temp luvs amy]

Probably around here somewhere?


Global politics, and all.

[fung_derf]

nice move! What's the target price again?

[temp luvs amy]

Nobody really knows. Somebody on the China Trading Stocks board suggested that anything medical in China has been hot.

I would guess that an institution did their DD and decided to take a position. The rest was just followers.

[fung_derf]

So what happened here today?

[maverick one]

It's undervalued still IMO- but I hear ya it's hard to resist take $ off table.

[temp luvs amy]

The thrill of the trade usually gets me to sell some short term.

I will try to hold onto some.

[maverick one]

I concur- long as well.

[maverick one]

Thanks: Initial entry 155,000 under $1.60- 50,000 shares at $1.95.

No intention of selling-long term hold. Up $206K and climbing.

If they keep same div-$61,500 is all mine.

It's always sweet when you beat the Street.

I hold CCCL as well- less div- Goldman Sachs huge stake.

But this one- had more upside- analyzed it- jumped on it.

[temp luvs amy]

Congrats.

I guess the institutions suddenly decided to add daily.

[maverick one]

I'm in-long as well- adding monthly. Nice div & undervalued.

[temp luvs amy]

New long here.

Love the financials.

[CA CHASE]

CHART



CA NPD $

[CA CHASE]

NPD RELEASES ANNUAL DIVIDEND OF $0.32 PER SHARE!

CA NPD

[CA CHASE]

PRINTING $2.00 AGAIN! HOD! NPD SEVERELY UNDERVALUED!

[Bid_Wack]

Looking strong. Nice Morning Star on the chart. Ready for a good move.

[CA CHASE]

NPD IS GOING NOWHERE BUT UP! SEE YOU AT $10!!!!

[CA CHASE]

BARCHART

[CA CHASE]

[CA CHASE]

China Nepstar Chain Drugstore Ltd. Reports Second Quarter 2013 Financial Results
Print
Alert
China Nepstar Chain Drugstore Ltd American Depositary Shares (NYSE:NPD)
Historical Stock Chart
2 Months : From Aug 2013 to Oct 2013

Click Here for more China Nepstar Chain Drugstore Ltd American Depositary Shares Charts.
SHENZHEN, China, Aug. 29, 2013 /PRNewswire-FirstCall/ -- China Nepstar Chain Drugstore Ltd. (NYSE: NPD) ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the second quarter ended June 30, 2013.

Financial Highlights

For the quarter ended June 30, 2013:

Same store sales increased by 8.6% compared with the second quarter of 2012
Revenue increased to RMB638.8 million (US$104.1 million) compared with RMB617.6 million for second quarter 2012
Loss from operations was RMB1.0 million (US$0.2 million), compared with income from operations of RMB 3.9 million for the second quarter 2012.
Net cash-flow from operating activities was RMB14.6 million (US$2.4 million), compared to RMB30.2 million in second quarter 2012
Mr. Fuxiang Zhang, Chief Executive Officer of Nepstar, commented, "During the second quarter, we adopted a more proactive marketing strategy to propel growth in revenue and to improve our store productivity. As a result, our average daily store traffic increased by eleven visits and same store sales grew by 8.6%, with fewer operating stores compared with the second quarter of 2012. While this promotional strategy has impacted our near-term gross margin and profitability, we believe the longer-term benefit of increased store traffic and participation in our loyalty programs will provide sustainable growth in margin over time and will ultimately enhance our competitiveness."

Second Quarter Results

During the second quarter of 2013, the Company opened 25 new stores and closed 48 stores. As of June 30, 2013, the Company had 2,071 directly operated stores in total.

Revenue for the second quarter of 2013 increased by 3.4% to RMB638.8 million (US$104.1 million) from RMB617.6 million for the same period in 2012. Same store sales (for the 1,969 stores opened before December 31, 2011 and were still operating) for the second quarter of 2013 increased by 8.6% compared with the same period in 2012. The increase in same store sales was primarily due to promotional initiatives aimed at increasing store traffic.

Second quarter revenue contribution by product category was 22.3% from prescription drugs; 38.2% from over-the-counter ("OTC") drugs; 14.8% from nutritional supplements; 4.0% from herbal products; and 20.7% from convenience and other products.

Second quarter gross profit was RMB280.8 million (US$45.7 million), a slight decrease from RMB287.5 million for the same period in 2012. Gross margin in the second quarter of 2013 was 44.0% compared with 46.5% for the same period of 2012. This decrease in gross margin was primarily the result of a more proactive marketing strategy for promoting the convenience and other products category.

The Company's portfolio of private label products was expanded to 2,069 types of products as of June 30, 2013. Sales of private label products represented approximately 25.0% of the Company's revenue and 33.8% of gross profit for the second quarter of 2013.

Sales, marketing and other operating expenses, as a percentage of revenue, in the second quarter of 2013 decreased to 38.9% from 40.8% in the same period of 2012. This decrease was primarily due to growth in same store sales and closure of underperforming stores.

General and administrative expenses as a percentage of revenue in the current quarter was 4.6%, compared with 5.1% for the same period in 2012. This decrease was mainly due to the continued implementation of rigorous cost control measures.

During the second quarter, we recognized impairment loss of RMB 3.4 million, which represents the reduction of the carrying amount of the property and equipment of certain underperforming stores.

Loss from operations in the second quarter of 2013 was RMB1.0 million (US$0.2 million), compared with income from operations of RMB3.9 million in the same period in 2012. The loss from operations in the second quarter of 2013 was mainly due to lower gross margin and the impairment loss. Excluding the impairment charge, income from operations was RMB 2.3 million (US$0.4 million).

Interest income for the second quarter of 2013 was RMB4.2 million (US$0.7 million) compared with RMB3.9 million in the same period in 2012.

Dividend income from cost method investments was RMB0.4 million (US$0.1 million) in the second quarter of 2013, compared with RMB3.1 million in the same period of 2012. On December 28, 2012, the Company completed the sale of its entire 40% equity interests in Yunnan Jianzhijia Chain Drugstore Ltd. for a total cash consideration of approximately RMB 81.5 million. Equity in income of an equity method investee was nil in the second quarter of 2013, compared with a loss of RMB1.0 million in the same period in 2012.

The Company's effective tax rate was 208.0% for the second quarter of 2013, compared with 74.9% for the same period in 2012. The Company's income tax expense was RMB 7.5 million for the second quarter of 2013, compared with RMB 7.4 million for the same period in 2012. The amounts of income tax expense were stable compared with the same period last year, and the higher effective rate for the current quarter was mainly due to the effect of operating losses from certain of our loss-making subsidiaries, for which full valuation allowances were made on their deferred tax assets.

Net loss for the second quarter of 2013 was RMB3.9 million (US$0.6 million), which represented RMB0.04 (US$0.01) basic and diluted loss per ADS. Net income for the second quarter of 2012 was RMB2.5 million, which represented RMB0.02 basic and diluted earnings per ADS.

Net cash-flow from operating activities in the second quarter of 2013 was RMB14.6 million (US$2.4 million), compared with RMB30.2 million for the same period in 2012.

As of June 30, 2013, the Company's total cash, cash equivalents, bank deposits and restricted cash were RMB666.0 million (US$108.5 million) and its shareholders' equity was RMB1.03 billion (US$167.6 million). This compares with total cash, cash equivalents, bank deposits and restricted cash of RMB664.4 million and shareholders' equity of RMB1.03 billion as of December 31, 2012.

Business Outlook

"Going forward, our focus remains on optimization of our product mix and maintaining momentum in store traffic and sales to stabilize and regain growth in margin and profitability," Mr. Zhang concluded. "Looking to the second half of the year, we expect same store sales and also the daily store traffic growth to continue."

Conference Call Information

The Company will host a conference call and a simultaneous webcast, on Thursday, August 29, 2013 at 8:00 a.m. Eastern Time / 8:00 p.m. Beijing Time. Interested parties may participate in the conference call by dialing in approximately five minutes before the appointed starting time at [phone] (North America) or [phone] (International). A live web cast of the conference call will be available on the Company's website at http://www.nepstar.cn.

A replay of the call will be available shortly after the conclusion of the conference call through September 5, 2013 at 11:59 p.m. Eastern Time. An archived web cast of the conference call will be available on the Company's website at http://www.nepstar.cn. Interested parties may access the replay by dialing [phone] (North America) or [phone] (International) and entering conference ID number 419160.

About China Nepstar Chain Drugstore Ltd.

China Nepstar Chain Drugstore Ltd. (NYSE: NPD) is the largest retail drugstore chain in China based on the number of directly operated stores. As of June 30 2013, the Company had 2,071 stores across 75 cities, one headquarter distribution center and 16 regional distribution centers in China. Nepstar uses directly operated stores, centralized procurement and a network of distribution centers to provide its customers with high-quality, professional and convenient pharmaceutical products and services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products, and convenience products. Nepstar's strategy of centralized procurement, competitive pricing, customer loyalty programs and private label offerings has enabled it to capitalize on the continuing economic growth in China and to take advantage of the demographic trend in China to achieve a strong brand and leading market position. For further information, please go to http://www.nepstar.cn.

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the quotations from management in this press release and the Company's strategic operational plans and business outlook, contain forward-looking statements. Such statements involve certain risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission, including its annual report on Form 20-F. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

Exchange Rate Information

The United States dollar (US$) amounts disclosed in this press release are presented solely for the convenience of the reader. Translations of amounts from RMB into United States dollars were calculated at the certified exchange rate of US$1.00 = RMB6.1374 on June 28, 2013 as set forth in the H.10 weekly statistical release of the Federal Reserve Board. No representation is made that the RMB amounts could have been, or could be, converted into US$ at that rate on June 28, 2013, or at any other date. The percentages stated are calculated based on RMB amounts.

Contacts

Zixin Shao
China Nepstar Chain Drugstore Ltd.
Chief Financial Officer
[phone]
[e-mail]

Dixon Chen
Grayling
Investor Relations
[phone]
[e-mail]

Ivette Almeida
Grayling
Media Relations
[phone]
[e-mail]

Tables follow



China Nepstar Chain Drugstore Ltd.

Unaudited Condensed Consolidated Statements of Comprehensive Income/(Loss)

(amounts in thousands – except per-share and per-ADS data)

[CA CHASE]

NPD GOING NORTH! LOAD UP AND TIE YOUR HANDS BEHIND YOUR BACK!

CA NPD